Sign in
8-K/A

Current Report

LISATA THERAPEUTICS, INC. Filed Acc 0000320017-16-000092

Exit or restructuring costs · Impairment

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 2.06 Material impairments

From the SEC's structured data for this filing